TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.

M Staehler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.